Nicholas Johnston, Alis Biosciences founder
New fund will pressure flailing biotechs, as investor frustration boils over
The horde of zombie biotechs lurching ahead and barely surviving has reached a crisis level for some investors.
Now there’s a new investment fund targeting …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
